Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

Copyright 2014, SLACK Incorporated.

Détails bibliographiques
Publié dans:Ophthalmic surgery, lasers & imaging retina. - 2013. - 45(2014), 2 vom: 07. März, Seite 143-9
Auteur principal: Fileta, John B (Auteur)
Autres auteurs: Scott, Ingrid U, Flynn, Harry W Jr
Format: Article en ligne
Langue:English
Publié: 2014
Accès à la collection:Ophthalmic surgery, lasers & imaging retina
Sujets:Journal Article Meta-Analysis Angiogenesis Inhibitors VEGFA protein, human Vascular Endothelial Growth Factor A
LEADER 01000caa a22002652c 4500
001 NLM236452916
003 DE-627
005 20250216193056.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20140306-08  |2 doi 
028 5 2 |a pubmed25n0788.xml 
035 |a (DE-627)NLM236452916 
035 |a (NLM)24635156 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Fileta, John B  |e verfasserin  |4 aut 
245 1 0 |a Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 24.09.2014 
500 |a Date Revised 21.03.2022 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright 2014, SLACK Incorporated. 
520 |a BACKGROUND AND OBJECTIVE: To investigate the rate of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents, the spectrum of causative organisms, and associated visual acuity outcomes 
520 |a PATIENTS AND METHODS: PubMed articles containing the keywords "endophthalmitis" and "intravitreal" between January 2005 and May 2012 were identified and reviewed. Inclusion criteria included article in English, more than 100 intravitreal anti-VEGF injections, and report of adverse events including endophthalmitis after intravitreal injection 
520 |a RESULTS: Forty-three articles were analyzed. Endophthalmitis occurred after 197 of 350,535 intravitreal anti-VEGF injections (0.056%). The most common organisms isolated were coagulase-negative Staphylococcus (38.24%) and Streptococcus species (29.41%) 
520 |a CONCLUSION: The reported rate of endophthalmitis after intravitreal anti-VEGF injection is low. Coagulase-negative Staphylococcus and Streptococcus species were the most frequent causative organisms. Streptococcus species represent the causative organism of endophthalmitis after intravitreal VEGF injections at a higher rate than rates reported in the literature for endophthalmitis following most incisional intraocular surgeries. Among patients with endophthalmitis after intravitreal anti-VEGF injection, endophthalmitis caused by Streptococcus species is associated with poorer visual acuity outcomes than endophthalmitis caused by coagulase-negative Staphylococcus and culture-negative cases 
650 4 |a Journal Article 
650 4 |a Meta-Analysis 
650 7 |a Angiogenesis Inhibitors  |2 NLM 
650 7 |a VEGFA protein, human  |2 NLM 
650 7 |a Vascular Endothelial Growth Factor A  |2 NLM 
700 1 |a Scott, Ingrid U  |e verfasserin  |4 aut 
700 1 |a Flynn, Harry W  |c Jr  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 45(2014), 2 vom: 07. März, Seite 143-9  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnas 
773 1 8 |g volume:45  |g year:2014  |g number:2  |g day:07  |g month:03  |g pages:143-9 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20140306-08  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
912 |a GBV_ILN_1127 
951 |a AR 
952 |d 45  |j 2014  |e 2  |b 07  |c 03  |h 143-9